Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial

We have been alerted to some French investigators who should have been mentioned in the acknowledgments of this paper by Gordon K Wilcock and colleagues (9 December, pp 1445-9): Drs Joël Ankri and Renée Sebag-Lanoe and Professors Philippe Robert, J François Dartigues, and Bernard Forette.